Yohimban-16-carboxylic acid,17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester,(3b,16b,17a,18b,20a)-(CAS: 131-01-1)

This compound (CAS: 131-01-1) falls under various regulatory guidelines such as GHS (Global Harmonized System of Classification and Labeling of Chemicals) for hazardous substances, REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) for the European Union, and FDA/EPA requirements for the United States. Specific safety data sheets (SDS) and material safety data sheets (MSDS) should be consulted for detailed information on storage, handling, and disposal procedures.

In the synthesis of this compound (CAS: 131-01-1), alternatives include the use of other methoxybenzoyl derivatives or different carboxylic acid derivatives. Common reagents such as benzoyl chloride or other aromatic carboxylic acids can be considered as substitutes to achieve similar molecular structures.

The market for this compound (CAS: 131-01-1) is primarily driven by its use in research and development for pharmaceuticals and natural product chemistry. Recent trends indicate increased interest in its potential applications in treating erectile dysfunction and as a research tool for studying hormone receptors. Price trends and demand are influenced by these factors and the availability of similar compounds.

Waste containing this compound (CAS: 131-01-1) should be collected in appropriate sealed containers and disposed of through professional waste disposal services. Environmental protection precautions include ensuring that the waste does not come into contact with water or air, and it should be incinerated or treated according to local and international regulations to minimize environmental impact.